TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -1 | -1 | -14 | -48 | -47 | -21 | -22 |
| P | %wins | 50 | 50 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/14 16:19 | 7/28/14 | VCYT | Veracyte, Inc. | DE | Health | Health | Medical Laboratories | Brooks Julie | CA | O | EVP,GC,S | P.m | 16 | 14.69 | 1 | 1 | 56 | 3 | D | -3 | 12 | 0 | -5 | 3 | -2 | -4 | -3 | -14 | -48 | -48 | -25 | ||
7/23/14 16:48 | 7/21/14 | VCYT | Veracyte, Inc. | DE | Health | Health | Medical Laboratories | Brooks Julie | CA | O | EVP,Gene | P.m | 28 | 14.18 | 1 | 2 | New | 2 | D | -13 | -2 | -8 | -17 | -2 | 4 | 3 | 1 | -13 | -47 | -45 | -17 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |